Paper20034030
Alcoholic liver disease.
O'Shea RS and 4 others. Hepatology, 2010. Cited by 930 papers, by iCite.
Cite this record
ConductScience Library. Alcoholic liver disease. Papers, record 20034030. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20034030
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Diseases, Alcoholic | Major topic |
| Algorithms | |
| Hepatitis, Alcoholic | |
| Humans | |
| Liver Transplantation | |
| Risk Factors |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03160651 | Corticosteroids in Alcoholic Hepatitis | Background | ClinicalTrials.gov | |
| NCT05014087 | Digoxin In Treatment of Alcohol Associated Hepatitis | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 20432268 | Comments on AASLD practice guidelines for alcoholic liver disease. | https://conductscience.org/library/papers/20432268 |
Source PubMed
Cited by518
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 930 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42783733 | MetALD Molecular Signatures: What We Know, What We Lack, and How to Move Forward Through Integrated Multi-Omics. | Metabolites | 2026 | https://conductscience.org/library/papers/42783733 | PubMed |
| 42530482 | A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies. | Stat Med | 2026 | https://conductscience.org/library/papers/42530482 | PubMed |
| 42528288 | Biomarkers From the Microbiome to Predict ALD Progression and Its Severity: A Comprehensive Review. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42528288 | PubMed |
| 42515691 | Hugan Tablets Alleviate Alcoholic Liver Injury by Modulating Hepatic Glutathione Metabolism and PPARγ/NRF2/GPX4-Related Antioxidant Defense. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515691 | PubMed |
| 42262404 | Multiplexed targeted mRNA profiling of alcohol-related liver disease reveals stage-specific dysregulation of signaling pathways. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42262404 | PubMed |
| 42193401 | 4-Hexylresorcinol Attenuates Ethanol-Induced Hepatic and Pancreatic Injury by Modulating Metabolic Dysfunction and Endoplasmic Reticulum Stress. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193401 | PubMed |
| 42110990 | Quantitative rFRC-based evaluation of computational resolution enhancement in in vivo two-photon subcellular imaging. | Biomed Opt Express | 2026 | https://conductscience.org/library/papers/42110990 | PubMed |
| 41910418 | Demoralization, employment status, and early symptom reduction as correlates of treatment discontinuation in outpatient alcohol use disorder. | Alcohol Alcohol | 2026 | https://conductscience.org/library/papers/41910418 | PubMed |
| 41859047 | Chalinasterol attenuates ethanol-induced hepatic lipid accumulation by activating β-oxidation. | Biomed Rep | 2026 | https://conductscience.org/library/papers/41859047 | PubMed |
| 41583505 | Computational Resolution Enhancement of Mitochondria monitoring in Multiple Organs using Intravital Two-Photon Microscopy. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/41583505 | PubMed |
| 41566987 | Direct comparison of ultrasound-guided attenuation parameter and controlled attenuation parameter for steatosis using MRI-based proton density fat fraction as a reference. | Ultrasonography | 2026 | https://conductscience.org/library/papers/41566987 | PubMed |
| 41535037 | A Prospective Observational Study of AUDIT-based Risk Stratification and Drinking Guidance Provided by Hepatologists in Patients with Alcoholic Liver Disease. | Intern Med | 2026 | https://conductscience.org/library/papers/41535037 | PubMed |
| 41498198 | Impact of Evolving Evidence on Pharmacological Therapy for Alcohol-Associated Hepatitis in Alberta: A Population-Based Study of Practice Trends and MELD-Stratified Effectiveness of Corticosteroids. | Aliment Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41498198 | PubMed |
| 41368474 | Met-ALD and ALD- Does Differentiating These Impact Management and Clinical Outcomes? | Curr Hepatol Rep | 2025 | https://conductscience.org/library/papers/41368474 | PubMed |
| 41017315 | Physiological Mechanisms Vulnerable to Alcohol-Induced Alterations: Role in Chronic Comorbidities. | Compr Physiol | 2025 | https://conductscience.org/library/papers/41017315 | PubMed |
| 40857455 | Statistical methods for assessing treatment effects on ordinal outcomes using observational data. | Commun Stat Simul Comput | 2025 | https://conductscience.org/library/papers/40857455 | PubMed |
| 40612519 | Advancing hepatotoxicity assessment: current advances and future directions. | Toxicol Res | 2025 | https://conductscience.org/library/papers/40612519 | PubMed |
| 40599511 | Challenges in Managing Recurrent Small Bowel Obstruction in a Patient With Concurrent Hepatic Dysfunction and Alcohol Use Disorder: A Multidisciplinary Approach. | Cureus | 2025 | https://conductscience.org/library/papers/40599511 | PubMed |
| 40563995 | The Application of S-Substituted Pteridine for CCl4-Induced Acute Hepatitis Treatment in Rats. | Biomedicines | 2025 | https://conductscience.org/library/papers/40563995 | PubMed |
| 40430529 | Phytochemicals Targeting Inflammatory Pathways in Alcohol-Induced Liver Disease: A Mechanistic Review. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430529 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20034030
GET https://conductscience.org/api/papers/v1/20034030/cited_by?page=2